A detailed history of Geode Capital Management, LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,284,464 shares of CRMD stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,284,464
Previous 1,271,293 1.04%
Holding current value
$10.7 Million
Previous $5.5 Million 88.55%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$3.64 - $8.23 $47,942 - $108,397
13,171 Added 1.04%
1,284,464 $10.4 Million
Q2 2024

Aug 09, 2024

BUY
$4.08 - $6.39 $359,533 - $563,093
88,121 Added 7.45%
1,271,293 $5.5 Million
Q1 2024

May 13, 2024

BUY
$2.94 - $4.24 $71,630 - $103,303
24,364 Added 2.1%
1,183,172 $5.02 Million
Q4 2023

Feb 13, 2024

BUY
$3.0 - $4.01 $235,614 - $314,937
78,538 Added 7.27%
1,158,808 $4.36 Million
Q3 2023

Nov 13, 2023

BUY
$3.6 - $4.46 $825,141 - $1.02 Million
229,206 Added 26.93%
1,080,270 $4 Million
Q2 2023

Aug 11, 2023

BUY
$3.94 - $5.8 $1.88 Million - $2.77 Million
477,084 Added 127.57%
851,064 $3.37 Million
Q1 2023

May 15, 2023

BUY
$3.22 - $4.61 $54,942 - $78,660
17,063 Added 4.78%
373,980 $1.55 Million
Q4 2022

Feb 13, 2023

BUY
$2.81 - $4.45 $20,291 - $32,133
7,221 Added 2.06%
356,917 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$2.82 - $7.52 $52,852 - $140,939
18,742 Added 5.66%
349,696 $989,000
Q2 2022

Aug 12, 2022

SELL
$2.73 - $5.61 $902,109 - $1.85 Million
-330,443 Reduced 49.96%
330,954 $1.33 Million
Q1 2022

May 13, 2022

BUY
$3.83 - $6.24 $68,706 - $111,939
17,939 Added 2.79%
661,397 $3.62 Million
Q4 2021

Feb 11, 2022

SELL
$4.47 - $5.56 $123,126 - $153,150
-27,545 Reduced 4.11%
643,458 $2.93 Million
Q3 2021

Nov 12, 2021

BUY
$4.46 - $7.11 $178,221 - $284,115
39,960 Added 6.33%
671,003 $3.12 Million
Q2 2021

Aug 13, 2021

BUY
$6.05 - $10.09 $591,006 - $985,661
97,687 Added 18.32%
631,043 $4.33 Million
Q1 2021

May 12, 2021

BUY
$6.84 - $17.58 $503,512 - $1.29 Million
73,613 Added 16.01%
533,356 $5.33 Million
Q4 2020

Feb 12, 2021

BUY
$5.0 - $9.15 $239,495 - $438,275
47,899 Added 11.63%
459,743 $3.42 Million
Q3 2020

Nov 13, 2020

BUY
$3.96 - $6.15 $192,923 - $299,615
48,718 Added 13.42%
411,844 $2.48 Million
Q2 2020

Aug 13, 2020

BUY
$3.08 - $6.56 $19,773 - $42,115
6,420 Added 1.8%
363,126 $2.29 Million
Q1 2020

May 14, 2020

BUY
$2.35 - $7.08 $110,701 - $333,517
47,107 Added 15.22%
356,706 $1.28 Million
Q4 2019

Feb 13, 2020

BUY
$4.96 - $7.75 $65,100 - $101,718
13,125 Added 4.43%
309,599 $2.25 Million
Q3 2019

Nov 12, 2019

BUY
$6.38 - $9.69 $22,164 - $33,663
3,474 Added 1.19%
296,474 $1.89 Million
Q2 2019

Aug 14, 2019

BUY
$5.93 - $10.57 $801,896 - $1.43 Million
135,227 Added 85.71%
293,000 $2.63 Million
Q1 2019

May 14, 2019

BUY
$6.95 - $13.25 $1.1 Million - $2.09 Million
157,773 New
157,773 $1.49 Million

Others Institutions Holding CRMD

About CorMedix Inc.


  • Ticker CRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,208,200
  • Market Cap $343M
  • Description
  • CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...
More about CRMD
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.